Skip to content

Azur Pushable Helical 45-251014Recalls & reported problems

Microvention, Inc. · Azur · Class 2 · Implant

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00810170012556), received between Oct 28, 2020 and Oct 28, 2020 — classified as 1 injury.

The most frequently reported specific device problem is “Migration” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Most reported problems

Device problems

  • Migration1

Patient problems

  • Ischemia1
  • Pain1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryOct 28, 2020Migration; Migration

    IT WAS REPORTED THAT PERIPHERAL COIL EMBOLIZATION WAS PERFORMED FOR A SPLENIC ARTERY ANEURYSM. POST-DEPLOYMENT IMAGES DEMONSTRATED MIGRATION OF AN EMBOLIZATION COIL TO THE SPLENIC HILUM. THE PATIENT EXPERIENCED INCREASING PAIN OVER THE FOLLOWING TWO WEEKS, WHICH WAS MANAGED WITH MEDICATIONS. SUBSEQUENT CT IMAGING TAKEN 17 DAYS POST-PROCEDURE DEMONSTRATED SEGMENTAL SPLENIC INFARCTION. THE PATIENT'S CURRENT STATUS HAS NOT BEEN PROVIDED.

    Patient problems: Ischemia; Pain

    MAUDE report 10752776 ↗

Other Device, Vascular, for Promoting Embolization devices

All Device, Vascular, for Promoting Embolization devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page